MUC1-CEA-ERBB2-telomerase-BIRC5-MAGEA1-RNA-vaccine - CureVac
Alternative Names: mRNA RCC vaccine - CureVac; mRNA renal cell carcinoma vaccine - CureVac; Mucin-1 carcinoembryonic antigen ERBB2 telomerase BIRC5 MAGEA1 RNA vaccine; RNAactive RCC vaccine - CureVac; RNAactive renal cell carcinoma vaccine - CureVac; TAA mRNA vaccine - CureVacLatest Information Update: 31 Mar 2015
Price :
$50 *
At a glance
- Originator CureVac
- Class Cancer vaccines; RNA vaccines
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Renal cancer
Most Recent Events
- 13 Mar 2015 No development reported - Phase-I/II for Renal cancer in Germany (Intradermal)